About Moderna, Inc.

Moderna, Inc. (NASDAQ: MRNA) is a Healthcare company (Biotechnology) with a market capitalization of $98.1B. Its Maz Rating is 3.04 out of 5 (B+, Buy), ranked against the other companies in its sector.

Factor scores: Valuation 1.12, Growth 1.57, Profitability 3.00, Financial Health 2.61, Momentum 4.99 (as of 2026-10-16).

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

CEO

Stéphane Bancel

Employees

4,700

IPO date

2018-12-07